ATTO- Attovia Therapeutics, Inc.

Trade Summary

1 month ago, Frazier Life Sciences XI, L.P., serving as 10% owner Owner at Attovia Therapeutics, Inc. (ATTO), purchased 588,235 shares at $17.00 per share, for a total transaction value of $9,999,995.00. Following this transaction, Frazier Life Sciences XI, L.P. now holds 6,154,213 shares of ATTO.

This purchase represents a 10.57% increase in Frazier Life Sciences XI, L.P.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, August 6, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, August 6, 2026 at 5:35 PM ET, meaning the disclosure happened on the same day as the trade.

Attovia Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.